Article Text

PDF
Response to: ‘Detection of myositis-specific antibodies: additional notes’ by Infantino et al
  1. Anna Tjärnlund1,
  2. Ingrid E Lundberg1,
  3. Johan Rönnelid2
  1. 1Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
  2. 2Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
  1. Correspondence to Anna Tjärnlund, Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm S-171 76, Sweden; anna.tjarnlund{at}ki.se

Statistics from Altmetric.com

We have with great interest read the response letter by Dr Infantino and colleagues on testing of methodologies used for detection of myositis-specific antibodies (MSA), to be published in the Annals of the Rheumatic Diseases.1 The authors discuss the need for validation of methodologies used for identifying MSA. The discussion stems from the publication of the new classification criteria for idiopathic inflammatory myopathies (IIM) ‘2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups’ that …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles